Latest Insider Transactions at Senseonics Holdings, Inc. (SENS)
This section provides a real-time view of insider transactions for Senseonics Holdings, Inc. (SENS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Senseonics Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Senseonics Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 31
2022
|
John Marotta Director |
BUY
Grant, award, or other acquisition
|
Direct |
66,372
+50.0%
|
-
|
|
Oct 03
2022
|
Edelman Steven |
BUY
Grant, award, or other acquisition
|
Direct |
7,371
+1.42%
|
-
|
|
Oct 03
2022
|
Douglas S Prince |
BUY
Grant, award, or other acquisition
|
Direct |
7,156
+1.67%
|
-
|
|
Oct 03
2022
|
Edward Fiorentino |
BUY
Grant, award, or other acquisition
|
Direct |
10,782
+1.89%
|
-
|
|
Oct 03
2022
|
Stephen P De Falco |
BUY
Grant, award, or other acquisition
|
Direct |
19,083
+1.39%
|
-
|
|
Sep 01
2022
|
Frederick T. Sullivan Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
62,147
+7.82%
|
-
|
|
Aug 04
2022
|
Mukul Jain Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
50,000
-1.96%
|
$50,000
$1.97 P/Share
|
|
Jul 01
2022
|
Edelman Steven |
BUY
Grant, award, or other acquisition
|
Direct |
9,466
+1.85%
|
-
|
|
Jul 01
2022
|
Douglas S Prince |
BUY
Grant, award, or other acquisition
|
Direct |
9,191
+2.17%
|
-
|
|
Jul 01
2022
|
Edward Fiorentino |
BUY
Grant, award, or other acquisition
|
Direct |
13,848
+2.46%
|
-
|
|
Jul 01
2022
|
Stephen P De Falco |
BUY
Grant, award, or other acquisition
|
Direct |
24,509
+1.81%
|
-
|
|
Jun 15
2022
|
Mukul Jain Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
38,018
-1.52%
|
$0
$0.97 P/Share
|
|
Jun 15
2022
|
Francine Kaufman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,352
-0.46%
|
$0
$0.97 P/Share
|
|
Jun 15
2022
|
Timothy T Goodnow President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
105,219
-1.66%
|
$0
$0.97 P/Share
|
|
Jun 15
2022
|
Kenneth L Horton GC & Corp. Development Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
26,105
-1.58%
|
$0
$0.97 P/Share
|
|
May 26
2022
|
Stephen P De Falco |
BUY
Grant, award, or other acquisition
|
Direct |
99,557
+7.08%
|
-
|
|
May 26
2022
|
Edelman Steven |
BUY
Grant, award, or other acquisition
|
Direct |
99,557
+16.77%
|
-
|
|
May 26
2022
|
Edward Fiorentino |
BUY
Grant, award, or other acquisition
|
Direct |
99,557
+15.7%
|
-
|
|
May 26
2022
|
Timothy T Goodnow President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,901,932
+12.35%
|
-
|
|
May 26
2022
|
Kenneth L Horton GC & Corp. Development Advisor |
BUY
Grant, award, or other acquisition
|
Direct |
476,035
+12.15%
|
-
|
|
May 26
2022
|
Sharon Larkin |
BUY
Grant, award, or other acquisition
|
Direct |
99,557
+36.21%
|
-
|
|
May 26
2022
|
Mukul Jain Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
820,863
+12.88%
|
-
|
|
May 26
2022
|
Francine Kaufman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,863
+6.94%
|
-
|
|
May 26
2022
|
Nick B. Tressler Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
397,000
+20.7%
|
-
|
|
May 26
2022
|
Anthony R. Raab |
BUY
Grant, award, or other acquisition
|
Direct |
99,557
+23.92%
|
-
|
|
May 26
2022
|
Douglas S Prince |
BUY
Grant, award, or other acquisition
|
Direct |
99,557
+19.71%
|
-
|
|
May 26
2022
|
Douglas A Roeder |
BUY
Grant, award, or other acquisition
|
Direct |
99,557
+38.35%
|
-
|
|
May 16
2022
|
Timothy T Goodnow President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
297,117
-6.27%
|
$297,117
$1.13 P/Share
|
|
May 16
2022
|
Kenneth L Horton GC & Corp. Development Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
45,430
-3.73%
|
$45,430
$1.13 P/Share
|
|
May 16
2022
|
Mukul Jain Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
114,117
-6.17%
|
$114,117
$1.13 P/Share
|
|
May 16
2022
|
Francine Kaufman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
54,538
-4.46%
|
$54,538
$1.13 P/Share
|
|
May 16
2022
|
Nick B. Tressler Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,850
-2.55%
|
$7,850
$1.13 P/Share
|
|
Apr 01
2022
|
Stephen P De Falco |
BUY
Grant, award, or other acquisition
|
Direct |
12,886
+1.06%
|
$12,886
$1.94 P/Share
|
|
Apr 01
2022
|
Edward Fiorentino |
BUY
Grant, award, or other acquisition
|
Direct |
7,280
+1.65%
|
$7,280
$1.94 P/Share
|
|
Apr 01
2022
|
Edelman Steven |
BUY
Grant, award, or other acquisition
|
Direct |
4,977
+1.25%
|
$4,977
$1.94 P/Share
|
|
Apr 01
2022
|
Douglas S Prince |
BUY
Grant, award, or other acquisition
|
Direct |
4,832
+1.56%
|
$4,832
$1.94 P/Share
|
|
Apr 01
2022
|
Sharon Larkin |
BUY
Grant, award, or other acquisition
|
Direct |
3,745
+4.7%
|
$3,745
$1.94 P/Share
|
|
Mar 11
2022
|
Edward Fiorentino |
SELL
Open market or private sale
|
Direct |
63,553
-12.94%
|
$63,553
$1.65 P/Share
|
|
Mar 11
2022
|
Edward Fiorentino |
BUY
Exercise of conversion of derivative security
|
Direct |
83,900
+14.59%
|
$0
$0.54 P/Share
|
|
Feb 11
2022
|
Timothy T Goodnow President and CEO |
SELL
Open market or private sale
|
Direct |
464,390
-8.93%
|
$928,780
$2.46 P/Share
|
|
Feb 11
2022
|
Kenneth L Horton GC & Corp. Development Advisor |
SELL
Open market or private sale
|
Direct |
143,126
-10.52%
|
$286,252
$2.46 P/Share
|
|
Feb 11
2022
|
Mukul Jain Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
150,197
-7.51%
|
$300,394
$2.46 P/Share
|
|
Feb 11
2022
|
Francine Kaufman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
163,870
-11.82%
|
$327,740
$2.46 P/Share
|
|
Feb 11
2022
|
Mirasol Panlilio VP Global Sales and Marketing |
SELL
Open market or private sale
|
Direct |
105,760
-8.89%
|
$211,520
$2.46 P/Share
|
|
Feb 11
2022
|
Nick B. Tressler Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
72,873
-19.16%
|
$145,746
$2.46 P/Share
|
|
Feb 10
2022
|
Timothy T Goodnow President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
673,268
+11.46%
|
-
|
|
Feb 10
2022
|
Kenneth L Horton GC & Corp. Development Advisor |
BUY
Grant, award, or other acquisition
|
Direct |
255,287
+15.8%
|
-
|
|
Feb 10
2022
|
Mukul Jain Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
260,483
+11.53%
|
-
|
|
Feb 10
2022
|
Francine Kaufman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
310,884
+18.32%
|
-
|
|
Feb 10
2022
|
Mirasol Panlilio VP Global Sales and Marketing |
BUY
Grant, award, or other acquisition
|
Direct |
210,020
+15.01%
|
-
|